NCT06107049 is a NA clinical trial of BLa80 in Poor Quality Sleep, sponsored by Wecare Probiotics Co., Ltd..

Who is sponsoring NCT06107049?

NCT06107049 is sponsored by Wecare Probiotics Co., Ltd..

What drugs are being tested in NCT06107049?

Interventions in NCT06107049: BLa80.

What condition does NCT06107049 study?

NCT06107049 studies Poor Quality Sleep.

Is NCT06107049 still recruiting?

NCT06107049 is currently completed. Last updated 26 April 2024.

Last reviewed 2024-04-26 · How we verify

NCT06107049

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

the Effect of Probiotic on Sleep Quality Management

Completed NA Last updated 26 April 2024

What this trial tests

NA trial testing BLa80 in Poor Quality Sleep in 110 participants. Completed in 30 March 2024.

Timeline

1 November 2023

Primary endpoint
30 March 2024

30 March 2024

Quick facts

Lead sponsor	Wecare Probiotics Co., Ltd.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	110
Start date	1 November 2023
Primary completion	30 March 2024
Estimated completion	30 March 2024
Sites	1 location across China

Drugs / interventions tested

BLa80

Conditions studied

Poor Quality Sleep — all drugs for Poor Quality Sleep →

Sponsor

Wecare Probiotics Co., Ltd. — full company profile →

Who can join

Adults 18 to 30, any sex, with Poor Quality Sleep. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to learn about the improvement of sleep quality of probiotic BLa 80 in 110 healthy college students. The main question it aims to answer is whether probiotic BLa80 can effectively improve the sleep quality of college students. The experiment commenced with participants continuously consuming the recommended amount of the probiotic powder for approximately 8 weeks. Simultaneously, they were required to fill out an "Effect Evaluation Form" every week and submit it to relevant department. At the end of the first and eighth weeks, participants underwent tests for five liver functions, four lipid profiles, blood sugar, and uric acid levels, as well as stool sample collection. They then completed the "Mid-Term Effect Evaluation Form".

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A double blinded randomized placebo trial of Bifidobacterium animalis subsp. lactis BLa80 on sleep quality and gut microbiota in healthy adults.
Liu Y, Chen Y, Zhang Q, Zhang Y, et al · · 2025 · cited 6× · PMID 40169760 · DOI 10.1038/s41598-025-95208-2

Verify or expand the search:

Other trials of BLa80

Trials testing the same drug.

NCT07287306 — Effects of BLa80 and LRa05 on the Gut Microbiota Metabolite Profile of Healthy Individuals · NA · recruiting
NCT06216587 — BLa80 Improve Drinkers' Gut Microbiota · NA · unknown

Other recruiting trials for Poor Quality Sleep

Currently open trials in the same condition.

NCT07218822 — Impact of Pistachio Consumption on Sleep · NA · recruiting
NCT06157840 — Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD · NA · recruiting
NCT06847074 — Rise & Shine: Promoting Sleep Quality in Chronic Stroke With Exercise · NA · recruiting

Other Wecare Probiotics Co., Ltd. trials

Trials by the same sponsor.

NCT07529457 — Akk09 in Adults With Constipation · NA · not yet recruiting
NCT07507955 — Probiotics for Constipation Relief in Adults · NA · not yet recruiting
NCT07462494 — Probiotic Intervention in Constipation · NA · not yet recruiting
NCT07462481 — Probiotic Improve Constipation · NA · recruiting
NCT07507929 — Probiotic for Weight Management in Overweight and Obese Adults · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06107049 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wecare Probiotics Co., Ltd.
Last refreshed: 26 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06107049.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing